# Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)

> **NCT04826588** · PHASE3 · COMPLETED · sponsor: **University Children's Hospital Basel** · enrollment: 76 (actual)

## Conditions studied

- Paediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS)

## Interventions

- **DRUG:** Methylprednisolone sodium succinate 10 mg/kg intravenously
- **BIOLOGICAL:** Human normal immunoglobulin (IVIg)

## Key facts

- **NCT ID:** NCT04826588
- **Lead sponsor:** University Children's Hospital Basel
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-23
- **Primary completion:** 2022-11-20
- **Final completion:** 2022-11-20
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2025-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04826588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04826588, "Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04826588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*